These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35834444)

  • 1. Efficacy and durability of bovine virus diarrhea (BVD) virus killed vaccine adjuvanted with monolaurin.
    Abd El Fadeel MR; Soliman EM; Allam AM; ElKersh MF; Abd El-Baky RM; Mustafa A
    PLoS One; 2022; 17(7):e0269031. PubMed ID: 35834444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of three experimental bovine viral diarrhea virus killed vaccines adjuvanted with combinations of Quil A cholesterol and dimethyldioctadecylammonium (DDA) bromide.
    Ridpath JF; Dominowski P; Mannan R; Yancey R; Jackson JA; Taylor L; Mediratta S; Eversole R; Mackenzie CD; Neill JD
    Vet Res Commun; 2010 Dec; 34(8):691-702. PubMed ID: 20872289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological response of guinea pigs to oily and aqueous inactivated vaccines containing a Brazilian isolate of the Bovine Viral Diarrhea Virus (BVDV).
    Jordão RS; Ribeiro CP; Pituco EM; Okuda LH; Del Fava C; Stefano Ed; Filho MM; Mehnert DU
    Res Vet Sci; 2011 Oct; 91(2):311-5. PubMed ID: 21316721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.
    Wang W; Shi X; Wu Y; Li X; Ji Y; Meng Q; Zhang S; Wu H
    Vet Immunol Immunopathol; 2014 Aug; 160(3-4):288-92. PubMed ID: 24880701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to bovine viral diarrhea virus (BVDV) vaccines detecting antibodies to BVDV subtypes 1a, 1b, 2a, and 2c.
    Fulton RW; Cook BJ; Payton ME; Burge LJ; Step DL
    Vaccine; 2020 May; 38(24):4032-4037. PubMed ID: 32336600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and T cell-mediated immune responses to bivalent killed bovine viral diarrhea virus vaccine in beef cattle.
    Platt R; Coutu C; Meinert T; Roth JA
    Vet Immunol Immunopathol; 2008 Mar; 122(1-2):8-15. PubMed ID: 18190971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of chimeric bovine viral diarrhea viruses containing glycoprotein E rns of heterologous pestiviruses and evaluation of the chimeras as potential marker vaccines against BVDV.
    Luo Y; Yuan Y; Ankenbauer RG; Nelson LD; Witte SB; Jackson JA; Welch SK
    Vaccine; 2012 Jun; 30(26):3843-8. PubMed ID: 22521286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
    Walz PH; Givens MD; Rodning SP; Riddell KP; Brodersen BW; Scruggs D; Short T; Grotelueschen D
    Vaccine; 2017 Feb; 35(7):1046-1054. PubMed ID: 28111144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-linked immunosorbent assay assessment of bovine viral diarrhea virus antigen in inactivated vaccines using polyclonal or monoclonal antibodies.
    Ludemann LR; Katz JB
    Biologicals; 1994 Mar; 22(1):21-7. PubMed ID: 8068310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International proficiency trial for bovine viral diarrhea virus (BVDV) antibody detection: limitations of milk serology.
    Wernike K; Beer M
    BMC Vet Res; 2022 May; 18(1):168. PubMed ID: 35524302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines.
    Reber AJ; Tanner M; Okinaga T; Woolums AR; Williams S; Ensley DT; Hurley DJ
    Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):61-77. PubMed ID: 16543046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
    Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
    PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and efficacy of freeze-dried inactivated vaccine against bovine viral diarrhea virus genotypes 1 and 2, bovine herpes virus type 1.1, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus.
    Abd El Fadeel MR; El-Dakhly AT; Allam AM; Farag TK; El-Kholy AA
    Clin Exp Vaccine Res; 2020 Jul; 9(2):119-125. PubMed ID: 32864368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of reproductive performance of primiparous dairy cattle following revaccination with either modified-live or killed multivalent viral vaccines in early lactation.
    Walz PH; Montgomery T; Passler T; Riddell KP; Braden TD; Zhang Y; Galik PK; Zuidhof S
    J Dairy Sci; 2015 Dec; 98(12):8753-63. PubMed ID: 26454300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
    Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC
    Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
    Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
    Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternally derived humoral immunity to bovine viral diarrhea virus (BVDV) 1a, BVDV1b, BVDV2, bovine herpesvirus-1, parainfluenza-3 virus bovine respiratory syncytial virus, Mannheimia haemolytica and Pasteurella multocida in beef calves, antibody decline by half-life studies and effect on response to vaccination.
    Fulton RW; Briggs RE; Payton ME; Confer AW; Saliki JT; Ridpath JF; Burge LJ; Duff GC
    Vaccine; 2004 Jan; 22(5-6):643-9. PubMed ID: 14741155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Bovine Herpesvirus Type I Expressing the Bovine Viral Diarrhea Virus E2 Protein Could Effectively Prevent Infection by Two Viruses.
    Liu CY; Guo H; Zhao HZ; Hou LN; Wen YJ; Wang FX
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of long-term antibody responses to two inactivated bovine viral diarrhoea virus (BVDV) vaccines.
    González AM; Arnaiz I; Yus E; Eiras C; Sanjuán M; Diéguez FJ
    Vet J; 2014 Mar; 199(3):424-8. PubMed ID: 24461201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of reproductive protection against bovine viral diarrhea virus provided by multivalent viral vaccines containing inactivated fractions of bovine viral diarrhea virus 1 and 2.
    Walz PH; Riddell KP; Newcomer BW; Neill JD; Falkenberg SM; Cortese VS; Scruggs DW; Short TH
    Vaccine; 2018 Jun; 36(26):3853-3860. PubMed ID: 29699786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.